FDC Limited

Aurangabad, India Founded: 1936 • Age: 90 yrs Listed
Pharmaceuticals and consumer healthcare products are manufactured and exported.
Request Access
Report Incorrect Data
Page last updated

About FDC Limited

FDC Limited is a publicly listed company based in Aurangabad (India) founded in 1936. Pharmaceuticals and consumer healthcare products are manufactured and exported. The company has 6,970 employees. Its chief executive, as recorded, is Ameya Chandavarkar. Its website fdcindia.com draws about 15 thousand monthly visits. Its Indian entity Fdc Limited reported revenue of ₹2,284 Cr. FDC Limited offers products and services including Electral and Zifi. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.

Company details

Manufacturer of pharmaceuticals and consumer healthcare products. It produces a diverse portfolio of medications, including oral rehydration salts, electrolyte powders and drinks, antibacterial and antifungal agents, and ophthalmic formulations. A significant portion of its production focuses on medications for patient care transitioning from hospital to home. The company also develops improved drug delivery platforms and process innovations across API synthesis, formulations, biotechnology, and functional foods. Its products are exported internationally.

Recognitions & Rankings of FDC Limited

India's Most Valuable Companies 2021 edition · Source: Hurun India
Rank#496
Valuation
₹5,688 Cr
  • Headquarters Aurangabad, India
  • Employees 6,970
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website fdcindia.com
  • Social LinkedIn Facebook YouTube
  • Legal Name Fdc Ltd.
Operational Areas
Healthcare → Traditional Health & Nutrition
Key Metrics
  • Market Cap
    ₹6,392 Cr

    FDC · NSE

  • Share Price
    ₹394.20

    +0.41% today

  • Revenue
    ₹2,171 Cr

    FY 2025-26 · +3.0% YoY

  • EBITDA
    ₹325 Cr

    Margin 15.0%

  • Net Profit
    ₹268 Cr

    FY 2025-26 · +5.5% YoY

  • P/E (TTM)
    19.3x

    P/B 2.4x

  • ROE
    11.8%

    ROCE 15.6%

  • Debt / Equity
    0.01

    Interest cover 1.9x

  • Employee Count
    6,970

Products & Services of FDC Limited

FDC Limited offers a comprehensive portfolio of products and services, including Electral and Zifi.

Electral
Oral Rehydration Salts

Products are developed for rehydration purposes to support health recovery

Zifi
Antibiotics

Antibacterial products are provided for infection treatment to aid patient care

Apps and channels of FDC Limited

its YouTube channel FDC Limited has 2.25K subscribers and 8 videos.

FDC Limited
YouTube 2.25K subscribers 8 videos Autos & Vehicles
Open channel

Videos from FDC Limited

The most watched videos on FDC Limited's YouTube channel, FDC Limited (2.25K subscribers). Click a video to play it here.

ENERZAL - ZERO
9.8K views
FDC Limited - Piflu Favipiravir Tablets
4.8K views
ENERZAL - ZERO (Ab Zero Hi Hai Hero)
3K views
FDC Limited #LendAHelpingHand
2.7K views

More on FDC Limited.

Board of directors of Fdc Limited (FDC Limited)

Fdc Limited is the primary company behind FDC Limited. The board of Fdc Limited currently have 10 directors; the longest-serving is Nandan Mohan Chandavarkar, appointed in 1993. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nandan Mohan Chandavarkar
DIN 00043511
Whole-time director30 Sep 199333 yrs 1 moFdc Limited
Ameya Ashok Chandavarkar
DIN 00043238
Whole-time director01 Apr 200224 yrs 7 moFdc Limited
Mohan Chandavarkar Anand
DIN 00043344
Managing Director01 Apr 200917 yrs 7 moFdc Limited
Ashok Anand Chandavarkar
DIN 00042719
Whole-time director01 Mar 201115 yrs 8 moFdc Limited
Nomita Ramdas Chandavarkar
DIN 00042332
Director02 Jun 201412 yrs 5 moFdc Limited
Mahesh Chandru Bijlani
DIN 08447258
Director10 May 20197 yrs 6 moFdc Limited
Vijay Maniar
DIN 00750905
Director04 Aug 20224 yrs 3 moFdc Limited
Vijay Nautamlal Bhatt
DIN 00751001
Director25 May 20233 yrs 5 moFdc Limited
Charuta Nityanath Mandke
DIN 08953268
Director07 Aug 20242 yrs 3 moFdc Limited
Kishore Mukund Saletore
DIN 01705850
Additional Director01 Apr 20267 moFdc Limited

People of FDC Limited

54 people are tracked at FDC Limited (19 in leadership, 35 in team); the tracked headcount is 6,970.

NameRoleGroup
Mohan Chandavarkar
Managing DirectorLeadership
Ameya Chandavarkar
CEOLeadership
Shrikant Gade
Senior Vice President ProcurementLeadership
Zafrullah Khan
Senior Vice President & Head- Human ResourcesLeadership
Varsha Katre
Company Secretary & Legal HeadLeadership
Nirmal Kumar
Sr General Manager - MarketingLeadership
Debashish Roy
Senior Vice President HRLeadership
Uday Jadhav
Senior Human Resources Business PartnerLeadership
Ashok A. Chandavarkar
Managing DirectorLeadership
Ritesh Dedhia
General ManagerLeadership
Urmila Naik - Self Leadership Expert
Head Of Quality AssuranceLeadership
Ashish Kumar Sharma
Head Of SalesLeadership
Premal Dave
Head Of SalesLeadership
Megha Menon
Head Of Marketing (electral Div.)Leadership
Shashank Vyapari
Associate Vice PresidentLeadership
Venkatesh Nallamchetty
Business Head-ukLeadership
Kalpesh J. Shah
Associate Vice President - ITLeadership
Deepak Behere
Section Head At ProductionLeadership
Rajesh Bhattacharjee
Head Of Learning And DevelopmentLeadership
Yogesh Zope
Senior Maintenance Officer (project)Team

34 more people are available in the full profile.

Premium access

Complete people profiles for FDC Limited

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of FDC Limited

FDC Limited is a publicly listed company on the NSE with ticker symbol FDC in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date02 May 2000
  • Listed onBSE: 531599
  • Listed entityFDC Ltd.
  • Exchange sectorHealth technology
  • ISININE258B01022
  • Share price₹348.55 (+2.98% on the day) · 2026-10-14
  • Market capitalisation₹5,503 Cr
  • Price to earnings19.4
  • EPS (diluted, trailing year)₹17.97
  • Dividend yield1.48%
  • Volume (last session)105,218

Financials of FDC Limited

Exchange-reported figures of Fdc Limited, the listed company behind FDC Limited (NSE: FDC).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹2,171 Cr
+3.0% YoY
EBITDA
₹325 Cr
+0.2% YoY
Profit After Tax
₹268 Cr
+5.5% YoY
Net Worth
₹2,485 Cr
+8.9% YoY
Total Assets
₹2,529 Cr
+8.2% YoY
Total Debt
₹15.47 Cr
-26.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2,1712,1081,9431,7841,5281,3331,344
Revenue growth+3.0%+8.5%+8.9%+16.7%+14.6%-0.8%-
EBITDA325325339251254332292
EBITDA margin+15.0%+15.4%+17.4%+14.1%+16.6%+24.9%+21.7%
Profit before tax375357396258289388320
Net profit268254289190211284236
Net profit margin+12.3%+12.0%+14.9%+10.6%+13.8%+21.3%+17.5%
EPS (₹)17.2916.3918.7511.7012.8217.8514.03
Balance sheet
Total assets2,5292,3382,1482,0281,9891,7491,563
Net worth2,4852,2812,0971,9821,9571,7341,547
Total debt15.4721.1720.5228.3232.2014.5415.08
Cash & bank50.0052.7726.2924.9438.6631.5832.32
Net working capital301251314266234212184
Cash flow
Cash from operations200318221155162207250
Cash from investing(110)(199)(17.08)11.20(145)(77.18)(98.42)
Cash from financing(93.33)(92.12)(202)(180)(9.84)(129)(142)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue572668585465473648492464
Revenue growth (YoY)+21.0%+3.0%+18.9%+0.1%-7.9%+1.6%--
Other income17.9447.6649.8920.8020.6335.5016.0818.83
EBITDA64.2914310631.4933.8114053.9846.65
EBITDA margin+11.2%+21.4%+18.2%+6.8%+7.1%+21.6%+11.0%+10.1%
Depreciation15.9815.1314.3514.7815.2014.9115.5613.36
Interest0.840.831.551.121.151.171.190.95
Profit before tax65.4117514036.3938.0916053.3151.17
Tax16.3542.2136.968.089.7238.4214.6314.14
Net profit49.0613210328.3128.3712138.6837.03
EPS (₹)3.018.146.351.741.757.452.382.28
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2,1262,0701,9161,7771,5191,3251,331
Revenue growth+2.7%+8.0%+7.8%+17.0%+14.6%-0.4%-
EBITDA331320338255247324284
EBITDA margin+15.6%+15.5%+17.7%+14.3%+16.3%+24.5%+21.3%
Profit before tax378368398266285380325
Net profit272261291197214275242
Net profit margin+12.8%+12.6%+15.2%+11.1%+14.1%+20.8%+18.2%
EPS (₹)17.5616.8118.8712.1113.0117.4514.43
Balance sheet
Total assets2,5372,3442,1482,0261,9801,7371,557
Net worth2,4932,2872,0971,9811,9491,7221,542
Total debt15.4721.0620.2727.6731.4314.0415.08
Cash & bank38.7840.9721.6520.8032.0626.8628.96
Net working capital287237305263224205182
Cash flow
Cash from operations200310221165162210239
Cash from investing(109)(199)(17.75)3.73(147)(84.15)(84.89)
Cash from financing(93.15)(92.10)(202)(180)(9.70)(126)(142)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue553655564458462642482459
Revenue growth (YoY)+19.7%+2.0%+17.1%-0.2%-8.6%+2.9%--
Other income18.6247.3447.1722.0720.9135.5931.4318.64
Total expenses491512453429427501429413
EBITDA61.6914311228.8234.9014152.8245.94
EBITDA margin+11.2%+21.8%+19.8%+6.3%+7.6%+22.0%+11.0%+10.0%
Depreciation15.9515.0914.3114.7515.1714.8715.5313.32
Interest0.830.821.501.121.151.161.180.94
Profit before tax63.5317414335.0239.4916167.5450.32
Tax15.8442.2535.897.8310.0138.6919.3313.87

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 09 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue572668585465473648492464
Revenue growth (YoY)+21.0%+3.0%+18.9%+0.1%-7.9%+1.6%--
Other income17.9447.6649.8920.8020.6335.5016.0818.83
EBITDA64.2914310631.4933.8114053.9846.65
EBITDA margin+11.2%+21.4%+18.2%+6.8%+7.1%+21.6%+11.0%+10.1%
Depreciation15.9815.1314.3514.7815.2014.9115.5613.36
Interest0.840.831.551.121.151.171.190.95
Profit before tax65.4117514036.3938.0916053.3151.17
Tax16.3542.2136.968.089.7238.4214.6314.14
Net profit49.0613210328.3128.3712138.6837.03
EPS (₹)3.018.146.351.741.757.452.382.28
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2,1712,1081,9431,7841,5281,3331,344
Revenue growth+3.0%+8.5%+8.9%+16.7%+14.6%-0.8%-
Other income11490.6610249.8676.0997.0468.90
Total expenses1,8461,7831,6041,5331,2741,0011,052
Employee cost483482413391343296277
EBITDA325325339251254332292
EBITDA margin+15.0%+15.4%+17.4%+14.1%+16.6%+24.9%+21.7%
Depreciation59.2453.7339.9238.9437.3037.8137.46
Interest4.994.514.034.093.093.433.42
Profit before tax375357396258289388320
Tax93.1890.4391.1663.9773.2386.5280.07
Net profit268254289190211284236
Net profit margin+12.3%+12.0%+14.9%+10.6%+13.8%+21.3%+17.5%
EPS (₹)17.2916.3918.7511.7012.8217.8514.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital16.2816.2816.2816.5916.8816.8817.10
Reserves & surplus2,4692,2652,0811,9651,9401,7171,530
Shareholders' funds (net worth)2,4852,2812,0971,9821,9571,7341,547
Minority interest0.000.000.00(0.64)(0.43)(0.17)0.00
Secured loans0.000.000.000.000.000.000.00
Unsecured loans15.4721.1720.5228.3232.2014.5415.08
Total debt15.4721.1720.5228.3232.2014.5415.08
Total liabilities2,5292,3382,1482,0281,9891,7491,563
Assets
Gross block1,3741,180987973947898845
Net block999852680699705689674
Capital work in progress96.4913726119810519.2123.85
Investments1,0481,028843806886790665
Inventories355375389329305215210
Sundry debtors15210911712382.17111124
Cash & bank balances50.0052.7726.2924.9438.6631.5832.32
Loans & advances10367.4283.9093.4973.8951.8758.87
Total current assets660604616570499409425
Total current liabilities359353303304265196241
Net working capital301251314266234212184
Total assets2,5292,3382,1482,0281,9891,7491,563
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash51.4725.4223.8937.7330.4329.8819.92
Net cash from operating activities200318221155162207250
Net cash from investing activities(110)(199)(17.08)11.20(145)(77.18)(98.42)
Net cash from financing activities(93.33)(92.12)(202)(180)(9.84)(129)(142)
Net change in cash(2.79)26.051.53(13.84)7.290.559.96
Closing cash50.0052.7726.2924.9438.6631.5832.32
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.0%+8.5%+8.9%+16.7%+14.6%-0.8%-
EBITDA growth+0.2%-4.1%+34.9%-1.1%-23.6%+13.7%-
PBT growth+4.9%-9.9%+53.7%-10.9%-25.4%+21.2%+35.2%
Net income growth+5.5%-12.2%+52.3%-10.2%-25.5%+20.4%-
Revenue CAGR (3Y)+6.8%+11.3%+13.4%+9.9%+11.9%+7.4%+9.9%
EBITDA CAGR (3Y)+9.0%+8.6%+0.7%-4.9%+3.6%+13.6%+7.1%
Profitability & leverage
Net income margin+13.0%+12.7%+15.7%+10.9%+14.2%+22.6%+17.9%
Return on capital employed+15.6%+16.1%+19.2%+13.0%+15.7%+23.6%+21.5%
Return on net worth+11.8%+12.2%+15.0%+9.8%+11.7%+18.4%+16.0%
Debt / equity0.010.010.010.020.010.010.01
Long-term debt / equity0.000.010.010.010.010.010.00
Interest cover1.881.661.351.931.431.171.34
Efficiency & per share
Fixed asset turnover1.701.951.981.861.661.531.62
Inventory turnover5.955.525.425.635.886.287.01
Debtors turnover16.6618.6416.1917.4215.8611.3812.72
EPS (₹)17.2916.3918.7511.7012.8217.8514.03
Dividend per share (₹)5.005.000.000.000.000.000.80
Book value per share (₹)152.64140.11128.81119.47115.92102.7390.51
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue553655564458462642482459
Revenue growth (YoY)+19.7%+2.0%+17.1%-0.2%-8.6%+2.9%--
Other income18.6247.3447.1722.0720.9135.5931.4318.64
Total expenses491512453429427501429413
EBITDA61.6914311228.8234.9014152.8245.94
EBITDA margin+11.2%+21.8%+19.8%+6.3%+7.6%+22.0%+11.0%+10.0%
Depreciation15.9515.0914.3114.7515.1714.8715.5313.32
Interest0.830.821.501.121.151.161.180.94
Profit before tax63.5317414335.0239.4916167.5450.32
Tax15.8442.2535.897.8310.0138.6919.3313.87
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2,1262,0701,9161,7771,5191,3251,331
Revenue growth+2.7%+8.0%+7.8%+17.0%+14.6%-0.4%-
Other income11110610353.9178.7397.1582.66
Total expenses1,7951,7501,5781,5221,2721,0011,048
Employee cost476477409387340294276
EBITDA331320338255247324284
EBITDA margin+15.6%+15.5%+17.7%+14.3%+16.3%+24.5%+21.3%
Depreciation59.1053.6139.7338.7637.0837.6237.36
Interest4.924.494.004.043.053.403.41
Profit before tax378368398266285380325
Tax92.4494.0590.7864.7265.8285.9678.68
Net profit272261291197214275242
Net profit margin+12.8%+12.6%+15.2%+11.1%+14.1%+20.8%+18.2%
EPS (₹)17.5616.8118.8712.1113.0117.4514.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital16.2816.2816.2816.5916.8816.8817.10
Reserves & surplus2,4762,2712,0811,9641,9321,7051,525
Shareholders' funds (net worth)2,4932,2872,0971,9811,9491,7221,542
Secured loans0.000.000.000.000.000.000.00
Unsecured loans15.4721.0620.2727.6731.4314.0415.08
Total debt15.4721.0620.2727.6731.4314.0415.08
Total liabilities2,5372,3442,1482,0261,9801,7371,557
Assets
Gross block1,3691,176986972942891841
Net block994848676695701685670
Capital work in progress96.4913626119810419.2123.85
Investments1,0701,050850806886790665
Inventories344368383323304213209
Sundry debtors14210411512179.71108124
Cash & bank balances38.7840.9721.6520.8032.0626.8628.96
Loans & advances11270.8584.8210172.4251.6358.42
Total current assets637583605566488400421
Total current liabilities349346300303264195239
Net working capital287237305263224205182
Total assets2,5372,3442,1482,0261,9801,7371,557
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash39.6720.7719.7531.1325.7226.5214.36
Net cash from operating activities200310221165162210239
Net cash from investing activities(109)(199)(17.75)3.73(147)(84.15)(84.89)
Net cash from financing activities(93.15)(92.10)(202)(180)(9.70)(126)(142)
Net change in cash(2.21)18.901.02(11.38)5.41(0.80)12.16
Closing cash38.7840.9721.6520.8032.0626.8628.96
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.7%+8.0%+7.8%+17.0%+14.6%-0.4%-
EBITDA growth+3.5%-5.4%+33.0%+3.1%-23.9%+14.4%-
PBT growth+2.9%-7.6%+49.8%-6.9%-25.0%+16.9%+37.7%
Net income growth+4.5%-10.4%+47.9%-8.3%-22.1%+13.5%-
Revenue CAGR (3Y)+6.2%+10.9%+13.1%+10.1%+12.2%+7.7%+9.7%
EBITDA CAGR (3Y)+9.2%+9.1%+1.4%-3.5%+4.5%+14.0%+6.3%
Profitability & leverage
Net income margin+13.5%+13.2%+16.0%+11.3%+14.5%+22.2%+18.5%
Return on capital employed+15.7%+16.6%+19.3%+13.5%+15.5%+23.3%+22.0%
Return on net worth+12.0%+12.5%+15.1%+10.2%+12.0%+18.0%+16.6%
Debt / equity0.010.010.010.020.010.010.01
Long-term debt / equity0.000.010.010.010.010.010.00
Interest cover1.811.681.341.871.451.191.38
Efficiency & per share
Fixed asset turnover1.671.921.961.861.661.531.61
Inventory turnover5.985.515.425.675.886.276.97
Debtors turnover17.2718.9516.2517.6916.2011.4312.82
EPS (₹)17.5616.8118.8712.1113.0117.4514.43
Dividend per share (₹)5.005.000.000.000.000.000.80
Book value per share (₹)153.10140.48128.81119.39115.44102.0290.18

Web traffic of FDC Limited

The website of FDC Limited (fdcindia.com) receives about 15.3K visits a month and ranks #1,582,887 among all websites worldwide, #2,121 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    15.3K

    ▲ 2.4% vs previous month

  • Unique visitors
    6.9K

    per month

  • Global rank
    #1,582,887

    among all websites

  • Category rank
    #2,121

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with FDC Limited. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Blue Cross Laboratories
bluecrosslabs.com
100%
4.5K#2,591,597View details
Fresenius Kabi Oncology
fresenius-kabi-oncology.com
96%
1.7K#9,088,911View details
lupinworld.com
lupinworld.com
94%
–
Cadila Pharmaceuticals Limited
cadilapharma.com
89%
18.5K#1,452,788View details
iajpr.com
iajpr.com
72%
#6,921,362–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 16 similar websites and full traffic analytics for FDC Limited

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as FDC Limited (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Inventia Healthcare
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Strides Pharma Science
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M4,050
Sun Pharma
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.44 B19,801
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fdc Limited

FDC: Q2 REVENUE 5.72B RUPEES VS 4.73B (YOY)
Exchange Update • 14 days ago
FDC: Q2 CONS NET PROFIT 491M RUPEES VS 284M (YOY)
Exchange Update • 14 days ago
FDC: Q2 EBITDA 642M RUPEES VS 338M (YOY); Q2 EBITDA MARGIN 11.24% VS 7.15% (YOY)
Exchange Update • 14 days ago
FDC: Company's Board To Review Proposal For Buying Back Fully Paid Equity Shares Through Tender Offer
Exchange Update • 20 days ago
F D C Says High Court Granted Interim Stay To Impugned Notice Of FSSAI
Reuters • 2 months ago
F D C June-Quarter Consol Profit 1.32 Billion Rupees
Reuters • 3 months ago
Australian construction firm FDC files for IPO at $668 million valuation
Reuters • 4 months ago
F D C Says Food Safety Officials Visited Company's Warehouse At Chhatrapati Sambhaji Nagar And Nagpur
Reuters • 5 months ago
F D C March-Quarter Consol Profit 1.03 Billion Rupees
Reuters • 5 months ago
F D C Says Co Granted ANDA Approval By U.S. FDA For Cefixime Oral Suspension
Reuters • 5 months ago
Premium access

Complete news archive for FDC Limited

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FDC Limited

FDC Limited was founded in 1936.

FDC Limited is headquartered in Aurangabad, India. It is registered at Aurangabad, Maharashtra, India.

Ameya Chandavarkar is the CEO of FDC Limited, as recorded in our data.

FDC Limited has 6,970 employees.

The primary company behind FDC Limited, Fdc Limited, reported revenue of ₹2,284 Cr for FY 2026, up 3% year on year.

Manufacturer of pharmaceuticals and consumer healthcare products. It produces a diverse portfolio of medications, including oral rehydration salts, electrolyte powders and drinks, antibacterial and antifungal agents, and ophthalmic formulations. A significant portion of its production focuses on medications for patient care transitioning from hospital to home. The company also develops improved drug delivery platforms and process innovations across API synthesis, formulations, biotechnology, and functional foods. Its products are exported internationally.

FDC Limited offers Electral and Zifi.

Yes, FDC Limited is publicly traded on NSE under the ticker symbol FDC.

FDC Limited operates through Fdc Limited.

The legal entities of FDC Limited currently have 12 directors, including Mahesh Chandru Bijlani, Varsharani Rajaram Katre, Vijay Maniar and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available